Portolan Capital Management Has Lowered United Therapeutics (UTHR) Holding by $1.76 Million; Market Value Declined; As Apache (APA) Stock Declined, Gamco Investors Et Al Has Trimmed Its Stake by $1.20 Million

May 18, 2018 - By Henry Gaston

Apache Corporation (NYSE:APA) Logo

Mario Gabelli decreased its stake in Apache Corp (APA) by 31.47% based on its latest 2017Q4 regulatory filing with the SEC. Gamco Investors Inc Et Al sold 28,540 shares as the company’s stock declined 12.65% with the market. The hedge fund run by Mario Gabelli held 62,160 shares of the oil & gas production company at the end of 2017Q4, valued at $2.62M, down from 90,700 at the end of the previous reported quarter. Gamco Investors Inc Et Al who had been investing in Apache Corp for a number of months, seems to be less bullish one the $16.82 billion market cap company. The stock increased 3.16% or $1.35 during the last trading session, reaching $44.01. About 4.36 million shares traded. Apache Corporation (NYSE:APA) has declined 24.62% since May 18, 2017 and is downtrending. It has underperformed by 36.17% the S&P500.

George Mccabe decreased its stake in United Therapeutics Corporation (UTHR) by 25.9% based on its latest 2017Q4 regulatory filing with the SEC. Portolan Capital Management Llc sold 11,962 shares as the company’s stock declined 21.89% with the market. The hedge fund run by George Mccabe held 34,227 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $5.06 million, down from 46,189 at the end of the previous reported quarter. Portolan Capital Management Llc who had been investing in United Therapeutics Corporation for a number of months, seems to be less bullish one the $4.69 billion market cap company. The stock decreased 1.11% or $1.21 during the last trading session, reaching $107.7. About 296,274 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 23.69% since May 18, 2017 and is downtrending. It has underperformed by 35.24% the S&P500.

Investors sentiment decreased to 0.87 in Q4 2017. Its down 0.18, from 1.05 in 2017Q3. It worsened, as 61 investors sold APA shares while 238 reduced holdings. 78 funds opened positions while 183 raised stakes. 340.75 million shares or 2.35% less from 348.95 million shares in 2017Q3 were reported. Qci Asset invested 0% of its portfolio in Apache Corporation (NYSE:APA). Delta Asset Mngmt Lc Tn invested in 1.65% or 276,403 shares. Ipswich Mngmt Inc reported 6,230 shares or 0.11% of all its holdings. 6,970 are held by Gsa Cap Partners Llp. Litman Gregory Asset Ltd Co holds 0.01% or 1,000 shares. Pacific Heights Asset Mgmt Lc accumulated 200,000 shares or 0.83% of the stock. 11,887 are held by Steinberg Global Asset. Virtu Fin Limited Co invested 0.07% of its portfolio in Apache Corporation (NYSE:APA). Tiverton Asset Management Limited Liability Com invested 0.01% of its portfolio in Apache Corporation (NYSE:APA). 210,894 are held by Aviva Public Limited. 8,106 were reported by First Quadrant Limited Partnership Ca. Tdam Usa accumulated 9,298 shares. New York-based Ibm Retirement Fund has invested 0.04% in Apache Corporation (NYSE:APA). Boothbay Fund Mngmt Ltd Limited Liability Company holds 6,572 shares or 0.04% of its portfolio. Victory Management Inc holds 0% or 6,021 shares in its portfolio.

Since December 13, 2017, it had 2 insider purchases, and 0 insider sales for $204,572 activity.

Among 29 analysts covering Apache Corporation (NYSE:APA), 7 have Buy rating, 6 Sell and 16 Hold. Therefore 24% are positive. Apache Corporation had 106 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley on Wednesday, October 18 with “Equal-Weight”. The firm earned “Sector Perform” rating on Friday, May 6 by RBC Capital Markets. The firm earned “Overweight” rating on Tuesday, September 29 by Simmons & Co. As per Thursday, June 15, the company rating was maintained by RBC Capital Markets. Credit Suisse initiated Apache Corporation (NYSE:APA) on Wednesday, July 22 with “Neutral” rating. RBC Capital Markets maintained it with “Hold” rating and $55.0 target in Thursday, September 28 report. The firm has “Outperform” rating by Howard Weil given on Monday, May 16. On Friday, September 4 the stock rating was maintained by BMO Capital Markets with “Market Perform”. The company was maintained on Thursday, March 10 by Bernstein. As per Thursday, October 19, the company rating was maintained by Cowen & Co.

More important recent Apache Corporation (NYSE:APA) news were published by: Bizjournals.com which released: “Apache joins Noble Energy in anchoring new Permian-to-Corpus Christi pipeline” on May 14, 2018, also Globenewswire.com published article titled: “Apache Corporation Announces First-Quarter Financial and Operational Results”, Benzinga.com published: “5 Stocks In Clear Upward Trends” on April 20, 2018. More interesting news about Apache Corporation (NYSE:APA) was released by: Seekingalpha.com and their article: “Apache – It Will Pay To Be Patient” with publication date: May 08, 2018.

Gamco Investors Inc Et Al, which manages about $15.96B US Long portfolio, upped its stake in Heico Corp New Com (NYSE:HEI) by 20,231 shares to 103,656 shares, valued at $7.82M in 2017Q4, according to the filing. It also increased its holding in Paccar Inc (NASDAQ:PCAR) by 131,300 shares in the quarter, for a total of 272,300 shares, and has risen its stake in Textron Inc (NYSE:TXT).

Analysts await Apache Corporation (NYSE:APA) to report earnings on August, 2. They expect $0.31 earnings per share, up 247.62% or $0.52 from last year’s $-0.21 per share. APA’s profit will be $118.47 million for 35.49 P/E if the $0.31 EPS becomes a reality. After $0.32 actual earnings per share reported by Apache Corporation for the previous quarter, Wall Street now forecasts -3.13% negative EPS growth.

Among 12 analysts covering United Therapeutics (NASDAQ:UTHR), 2 have Buy rating, 3 Sell and 7 Hold. Therefore 17% are positive. United Therapeutics had 35 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by Ladenburg Thalmann to “Buy” on Friday, October 28. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned “Hold” rating by Cowen & Co on Thursday, July 27. The firm has “Outperform” rating given on Thursday, December 15 by Oppenheimer. The firm has “Hold” rating by H.C. Wainwright given on Friday, July 28. As per Friday, May 4, the company rating was maintained by Wedbush. Wedbush maintained the shares of UTHR in report on Thursday, January 4 with “Buy” rating. The firm has “Neutral” rating given on Friday, April 29 by Ladenburg Thalmann. The stock has “Neutral” rating by H.C. Wainwright on Wednesday, June 15. The rating was maintained by Wedbush with “Buy” on Monday, November 13. RBC Capital Markets maintained the stock with “Sector Perform” rating in Wednesday, July 29 report.

More notable recent United Therapeutics Corporation (NASDAQ:UTHR) news were published by: Nasdaq.com which released: “Mid-Morning Market Update: Markets Open Higher; Sprint And T-Mobile To Merge In $26 Billion Deal” on April 30, 2018, also Prnewswire.com with their article: “Stock Review for Drug Makers Investors — Endo, Ionis Pharma, Novo Nordisk, and United Therapeutics” published on April 30, 2018, Bizjournals.com published: “Analysts: Generic drugs won’t affect United Therapeutics ‘that much'” on May 09, 2018. More interesting news about United Therapeutics Corporation (NASDAQ:UTHR) were released by: Bizjournals.com and their article: “Taking out potential competition, drug maker says it will buy East Bay rival” published on April 30, 2018 as well as Streetinsider.com‘s news article titled: “Form 8-K SteadyMed Ltd. For: May 15” with publication date: May 15, 2018.

Portolan Capital Management Llc, which manages about $535.17M and $913.15 million US Long portfolio, upped its stake in Voya Financial Inc. (NYSE:VOYA) by 105,601 shares to 155,016 shares, valued at $7.67 million in 2017Q4, according to the filing. It also increased its holding in Wix .Com Ltd. (NASDAQ:WIX) by 13,665 shares in the quarter, for a total of 103,701 shares, and has risen its stake in Extraction Oil & Gas Inc..

Analysts await United Therapeutics Corporation (NASDAQ:UTHR) to report earnings on July, 26. They expect $2.57 earnings per share, up 305.60% or $3.82 from last year’s $-1.25 per share. UTHR’s profit will be $111.92M for 10.48 P/E if the $2.57 EPS becomes a reality. After $5.57 actual earnings per share reported by United Therapeutics Corporation for the previous quarter, Wall Street now forecasts -53.86% negative EPS growth.

Investors sentiment increased to 1.14 in Q4 2017. Its up 0.15, from 0.99 in 2017Q3. It is positive, as 26 investors sold UTHR shares while 112 reduced holdings. 53 funds opened positions while 105 raised stakes. 40.90 million shares or 1.42% less from 41.49 million shares in 2017Q3 were reported. Schroder Investment Grp Inc holds 0.21% or 858,195 shares. Cwm Limited Liability Company, a Nebraska-based fund reported 100 shares. Sumitomo Mitsui Incorporated reported 0.02% stake. 35,051 were accumulated by Voya Management Ltd Liability. Tudor Investment Corp Et Al holds 4,085 shares or 0.02% of its portfolio. Capital Impact Advisors Llc invested 1.03% in United Therapeutics Corporation (NASDAQ:UTHR). Hikari Pwr Ltd holds 0.2% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 11,490 shares. Toronto Dominion Commercial Bank holds 0% or 2,561 shares. Gsa Partners Llp reported 0.2% stake. Pennsylvania-based Sei Comm has invested 0% in United Therapeutics Corporation (NASDAQ:UTHR). Great West Life Assurance Can accumulated 103,612 shares. Chatham Cap Grp Inc, Georgia-based fund reported 9,690 shares. Paloma Prtnrs holds 0.01% or 6,760 shares in its portfolio. Apg Asset Mgmt Nv reported 0.16% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Etrade Mgmt Limited Liability Com accumulated 2,937 shares.

Since March 14, 2018, it had 0 insider buys, and 10 sales for $26.79 million activity.

Apache Corporation (NYSE:APA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Henry Gaston

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: